{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:52:30Z","timestamp":1783482750982,"version":"3.55.0"},"reference-count":80,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T00:00:00Z","timestamp":1292371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Based on experience from the treatment of other autoimmune diseases and because of the limitations imposed by existing therapeutic options for Graves\u2019 disease (GD) and thyroid\u2010associated ophthalmopathy (TAO), rituximab (RTX) was recently proposed as a novel therapy option. Here, we summarize the rationale for using RTX; give an overview of the possible mechanisms of action; and give an account of its effects and side\u2010effects when used in GD and TAO. Scant evidence, originating from only a few methodologically inhomogeneous studies, suggests that RTX may prolong remission for hyperthyroidism over that seen with antithyroid drugs, at least in mild GD. Furthermore, in patients with TAO, who are unresponsive to conventional immunosuppressive therapy, RTX seems efficacious. As we wait for larger\u2010scale randomized studies, RTX, should be considered experimental and reserved for patients who do not respond favourably to conventional therapy. It is the first in what is likely to be a series of new and emerging treatments specifically targeting relevant components of the immune system. Further studies will hopefully lead to improved and better tailored, individualized therapy for GD and especially TAO.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2010.03806.x","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T09:21:41Z","timestamp":1272014501000},"page":"1-8","source":"Crossref","is-referenced-by-count":38,"title":["Targeted biological therapies for Graves\u2019 disease and thyroid\u2010associated ophthalmopathy. Focus on B\u2010cell depletion with Rituximab"],"prefix":"10.1111","volume":"74","author":[{"given":"Laszlo","family":"Heged\u00fcs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010263431707"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0801880"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.930"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2009.01.009"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1991.1.129"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0806317"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0376"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02124"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.709"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02119"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg175"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.7.7.1061"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1701"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.2.205"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00772.x"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(03)00032-4"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0852"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.12.6348"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.942"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.5.3281"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5768"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/314537a0"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.8.4710"},{"key":"e_1_2_10_26_2","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.161.8.3912","article-title":"B lymphocytes are critical antigen\u2010presenting cells for the initiation of T cell\u2010mediated autoimmune diabetes in nonobese diabetic mice","volume":"161","author":"Serreze D.V.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_10_27_2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4049\/jimmunol.161.3.1163","article-title":"B lymphocytes are crucial antigen\u2010presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice","volume":"161","author":"Falcone M.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706383"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904452"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1626"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324413"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.4.1463"},{"key":"e_1_2_10_34_2","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.4049\/jimmunol.163.8.4284","article-title":"Dendritic cell\u2010derived IL\u201012 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development","volume":"163","author":"Skok J.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21438"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni833"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021293"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.12.5897"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00661.x"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61762-2"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/105072504774193159"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1238"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.138305"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21871"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22967"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01647.x"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2388"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02325"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0084"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.09.007"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001074107"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.130.5.2858"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215745"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02167.x"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0716"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.10.883"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20430"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029694"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21778"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22211"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.08.016"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2005.09.009"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel098"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.232"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.05.029"},{"key":"e_1_2_10_68_2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2009.03762.x","article-title":"Failure of rituximab treatment in a case of severe thyroid ophthalmopathy unresponsive to steroids","author":"Krassas G.E.","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.5.2049"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01087.x"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062505"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.07.001"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-197053"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken071"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737557"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20592"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0463"},{"key":"e_1_2_10_78_2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2009.03778.x","article-title":"Optimizing remission rates using antithyroid drugs for Graves\u2019 disease","author":"Heged\u00fcs L.","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20215"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0406"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2010.03806.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2010.03806.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:51:28Z","timestamp":1711414288000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2010.03806.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1365-2265.2010.03806.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03806.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,15]]}}}